Pdcd2L Activators
PDCD2L, short for Programmed Cell Death 2 Like, is a gene situated within the vast and intricate landscape of the human genome that encodes a protein with a role in the cellular life cycle, specifically within the context of apoptosis. The gene's ubiquitous expression profile, highlighted by pronounced activity in the testis and adipose tissue, underscores its fundamental importance across a diverse array of human tissues. This expression suggests that PDCD2L may have a hand in managing cell turnover and maintaining cellular health by eliminating cells that are no longer needed or are functioning improperly. The protein's localization to the membrane further implies a possible role in signaling pathways that dictate cell fate.
In the realm of molecular biology, the modulation of gene expression is a focal point of interest, and in the case of PDCD2L, certain chemical compounds have been hypothesized to upregulate its expression. These activators can vary widely in their origin and mechanism of action but share the commonality of influencing the pathways that govern the life cycle of cells. For example, DNA-damaging agents such as doxorubicin and cisplatin may stimulate the upregulation of PDCD2L by engaging the cellular DNA damage response, a highly conserved mechanism that signals the presence of genomic insult. Similarly, proteasome inhibitors like bortezomib could lead to an increase in PDCD2L expression as cells attempt to counteract the accumulation of damaged or misfolded proteins. Other compounds such as thapsigargin and tunicamycin, which induce endoplasmic reticulum stress, may also promote the expression of PDCD2L as part of the unfolded protein response, a cellular program aimed at restoring normal function of the endoplasmic reticulum. These activators, by interacting with cellular components and pathways, underscore the complexity of the regulatory networks that control gene expression and highlight the potential for diverse molecular interactions to dictate the expression levels of crucial genes like PDCD2L.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin can intercalate into DNA, disrupting topoisomerase-II-mediated DNA repair, which may trigger a cellular stress response that upregulates apoptotic genes, including PDCD2L. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin's inhibition of topoisomerase I leads to DNA damage, potentially triggering a cascade that activates p53 and subsequently upregulates PDCD2L as part of the apoptotic response. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
By inhibiting topoisomerase II, etoposide causes DNA strand breaks, which could stimulate the expression of PDCD2L through the activation of DNA damage response pathways. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin blocks N-linked glycosylation, causing ER stress and potentially stimulating a compensatory upregulation of PDCD2L as part of the unfolded protein response. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib's proteasome inhibition leads to the accumulation of misfolded proteins, which may upregulate PDCD2L expression as the cell initiates an apoptotic response to mitigate proteotoxic stress. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts and cross-links, which could stimulate the transcription of PDCD2L as part of the cellular effort to initiate apoptosis in response to genotoxic stress. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
As a broad-spectrum kinase inhibitor, staurosporine may induce PDCD2L expression by disrupting normal cell signaling pathways and promoting apoptotic processes. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea's inhibition of DNA synthesis may lead to replication stress and stimulate the upregulation of PDCD2L as the cell mounts a response to DNA damage. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
By disrupting the MDM2-p53 interaction, Nutlin-3 allows for the accumulation and activation of p53, which in turn can stimulate the expression of its target genes, possibly including PDCD2L. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac may induce apoptosis in certain cells through the inhibition of cyclooxygenase enzymes, potentially leading to the upregulation of PDCD2L in a response to disrupted prostaglandin synthesis. | ||||||